@article{2952986,
    title = "Efficacy and safety of weekly carfilzomib (70 mg/m2), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option: a cross-study comparison of the CANDOR and EQUULEUS studies",
    author = "Leleu, Xavier and Beksac, Meral and Chou, Takaaki and Dimopoulos, Meletios and Yoon, Sung-Soo and Prince, H Miles and Pour, Ludek and Shelekhova, Tatiana and Chari, Ajai and Khurana, Monica and others",
    journal = "Leukemia & Lymphoma",
    year = "2021",
    volume = "62",
    number = "2",
    pages = "358--367",
    publisher = "Taylor & Francis",
    issn = "1042-8194, 1029-2403"
}